GlaxoSmithKline PLC — Director's Dealing 2013

Jun 20, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5000H

GlaxoSmithKline PLC

20 June 2013

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in interests in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned Person Discharging Managerial Responsibility (PDMR) and his Connected Person on 18 June 2013:-

PDMR	GSK Share Option Plan
Mr P C Thomson	Exercise of option over 7,800 Ordinary shares, granted on 28 October 2003 under the GlaxoSmithKline Share Option Plan at a price of £12.68 per share, and sale of 7,800 Ordinary shares at a price of £16.81 per share. Exercise of option over 4,820 Ordinary shares, granted on 2 December 2004 under the GlaxoSmithKline Share Option Plan at a price of £11.23 per share, and sale of 4,820 Ordinary shares at a price of £16.815 per share. Exercise of option over 6,910 Ordinary shares, granted on 21 February 2006 under the GlaxoSmithKline Share Option Plan at a price of £14.68 per share, and sale of 6,910 Ordinary shares at a price of £16.815 per share. Exercise of option over 6,910 Ordinary shares, granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan at a price of £14.88 per share, and sale of 6,910 Ordinary shares at a price of £16.81387 per share. Exercise of option over 6,910 Ordinary shares, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan at a price of £11.47 per share, and sale of 6,910 Ordinary shares at a price of £16.810623 per share. Exercise of option over 6,910 Ordinary shares, granted on 17 February 2009 under the GlaxoSmithKline Share Option Plan at a price of £11.77 per share, and sale of 6,910 Ordinary shares at a price of £16.81 per share. Exercise of option over 6,910 Ordinary shares, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan at a price of £12.035 per share, and sale of 6,910 Ordinary shares at a price of £16.81 per share.
Connected Person	GSK Share Option Plan
Mrs K Thomson	Exercise of option over 6,000 Ordinary shares, granted on 28 October 2003 under the GlaxoSmithKline Share Option Plan at a price of £12.68 per share, and sale of 6,000 Ordinary shares at a price of £16.775 per share. Exercise of option over 1,570 Ordinary shares, granted on 2 December 2004 under the GlaxoSmithKline Share Option Plan at a price of £11.23 per share, and sale of 1,570 Ordinary shares at a price of £16.775 per share. Exercise of option over 974 Ordinary shares, granted on 21 February 2006 under the GlaxoSmithKline Share Option Plan at a price of £14.68 per share, and sale of 974 Ordinary shares at a price of £16.775 per share. Exercise of option over 1,005 Ordinary shares, granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan at a price of £14.88 per share, and sale of 1,005 Ordinary shares at a price of £16.775 per share. Exercise of option over 1,005 Ordinary shares, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan at a price of £11.47 per share, and sale of 1,005 Ordinary shares at a price of £16.775 per share. Exercise of option over 1,005 Ordinary shares, granted on 17 February 2009 under the GlaxoSmithKline Share Option Plan at a price of £11.77 per share, and sale of 1,005 Ordinary shares at a price of £16.775 per share. Exercise of option over 551 Ordinary shares, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan at a price of £12.035 per share, and sale of 551 Ordinary shares at a price of £16.775 per share. Exercise of option over 867 Ordinary shares, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan at a price of £12.035 per share, and sale of 867 Ordinary shares at a price of £16.775 per share.

The Company and the above-mentioned persons were advised of this information on 19 June 2013.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a) and (c).

V A Whyte

Company Secretary

20 June 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBBLFLXQFZBBX